2-166277030-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001365536.1(SCN9A):​c.2827A>C​(p.Met943Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0108 in 1,613,876 control chromosomes in the GnomAD database, including 1,236 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M943I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.015 ( 116 hom., cov: 32)
Exomes 𝑓: 0.010 ( 1120 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

2
3
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:14O:1

Conservation

PhyloP100: 6.19

Publications

39 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031083524).
BP6
Variant 2-166277030-T-G is Benign according to our data. Variant chr2-166277030-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 94089.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0929 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.2827A>C p.Met943Leu missense_variant Exon 16 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.2827A>C p.Met943Leu missense_variant Exon 16 of 27 NM_001365536.1 ENSP00000495601.1
SCN9AENST00000303354.11 linkc.2827A>C p.Met943Leu missense_variant Exon 16 of 27 5 ENSP00000304748.7
SCN9AENST00000409672.5 linkc.2794A>C p.Met932Leu missense_variant Exon 16 of 27 5 ENSP00000386306.1
SCN9AENST00000645907.1 linkc.2794A>C p.Met932Leu missense_variant Exon 16 of 27 ENSP00000495983.1

Frequencies

GnomAD3 genomes
AF:
0.0147
AC:
2230
AN:
151982
Hom.:
115
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00275
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0968
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.0579
Gnomad SAS
AF:
0.0141
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00338
Gnomad OTH
AF:
0.0143
GnomAD2 exomes
AF:
0.0368
AC:
9252
AN:
251290
AF XY:
0.0294
show subpopulations
Gnomad AFR exome
AF:
0.00301
Gnomad AMR exome
AF:
0.211
Gnomad ASJ exome
AF:
0.00258
Gnomad EAS exome
AF:
0.0595
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.00269
Gnomad OTH exome
AF:
0.0246
GnomAD4 exome
AF:
0.0103
AC:
15113
AN:
1461776
Hom.:
1120
Cov.:
31
AF XY:
0.00950
AC XY:
6907
AN XY:
727188
show subpopulations
African (AFR)
AF:
0.00191
AC:
64
AN:
33466
American (AMR)
AF:
0.192
AC:
8606
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00188
AC:
49
AN:
26132
East Asian (EAS)
AF:
0.0508
AC:
2015
AN:
39700
South Asian (SAS)
AF:
0.0116
AC:
999
AN:
86254
European-Finnish (FIN)
AF:
0.000168
AC:
9
AN:
53420
Middle Eastern (MID)
AF:
0.00312
AC:
18
AN:
5764
European-Non Finnish (NFE)
AF:
0.00242
AC:
2692
AN:
1111942
Other (OTH)
AF:
0.0109
AC:
661
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
902
1803
2705
3606
4508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0147
AC:
2239
AN:
152100
Hom.:
116
Cov.:
32
AF XY:
0.0163
AC XY:
1214
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.00275
AC:
114
AN:
41502
American (AMR)
AF:
0.0970
AC:
1481
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.0581
AC:
300
AN:
5166
South Asian (SAS)
AF:
0.0145
AC:
70
AN:
4814
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10590
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00338
AC:
230
AN:
67970
Other (OTH)
AF:
0.0151
AC:
32
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
101
202
302
403
504
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00883
Hom.:
117
Bravo
AF:
0.0236
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00407
AC:
35
ExAC
AF:
0.0295
AC:
3581
Asia WGS
AF:
0.0310
AC:
106
AN:
3478
EpiCase
AF:
0.00333
EpiControl
AF:
0.00225

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:14Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Sep 25, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 24% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 22. Only high quality variants are reported. -

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 02, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 07, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27956748, 23895530, 25585270, 22803682, 25556685, 25250524, 21698661, 26284228, 27535533, 21939494, 23450472) -

Channelopathy-associated congenital insensitivity to pain, autosomal recessive Benign:2
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

The p.Met932Leu variant in SCN9A has been identified in at least 2 Chinese individuals with partial congenital indifference to pain (PMID: 21939494). This variant is classified as likely benign for partial congenital indifference to pain because it has been identified in >23% of Latino chromosomes and 387 total homozygotes by ExAC (http://gnomad.broadinstitute.org/). -

Primary erythromelalgia Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Paroxysmal extreme pain disorder Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Autism spectrum disorder Other:1
Jul 28, 2023
Gene Friend Way, National Innovation Center
Significance:Uncertain risk allele
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. This variant and other mutations in SCN9A have been found in patients with familial autism (PMID: 27956748). In our study, about 10% of patients diagnosed with ASD carry this SCN9A variant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Pathogenic
0.20
CADD
Benign
23
DANN
Benign
0.93
DEOGEN2
Uncertain
0.53
.;D;.;.;D;.;.
Eigen
Benign
-0.23
Eigen_PC
Benign
0.052
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.79
T;.;T;T;T;T;T
MetaRNN
Benign
0.0031
T;T;T;T;T;T;T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
-0.10
.;N;.;.;N;N;.
PhyloP100
6.2
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-1.6
N;.;.;.;.;N;.
REVEL
Uncertain
0.57
Sift
Benign
0.31
T;.;.;.;.;T;.
Sift4G
Benign
1.0
T;T;.;.;.;T;.
Vest4
0.70
MutPred
0.65
Gain of helix (P = 0.062);.;Gain of helix (P = 0.062);Gain of helix (P = 0.062);.;.;.;
MPC
0.17
ClinPred
0.015
T
GERP RS
5.7
Varity_R
0.54
gMVP
0.73
Mutation Taster
=25/75
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12478318; hg19: chr2-167133540; COSMIC: COSV57599687; COSMIC: COSV57599687; API